Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting
NCT01034696 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2016-05-23
Summary
The primary objective of this research project is to estimate the number of patients with sarcoma or melanoma attending an outpatients clinic that are in pain or have unmet pain needs.
Conditions
- Sarcoma
- Melanoma
Sponsors & Collaborators
-
Royal Marsden NHS Foundation Trust
lead OTHER
Principal Investigators
-
Dr John Williams · Royal Marsden NHS Foundation Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-31
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom
NCT03448497 ·Status: COMPLETED
-
Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice
NCT05402059 ·Status: UNKNOWN
-
Serial Tumour Biopsies and Blood Biomarkers in Melanoma
NCT04493723 ·Status: RECRUITING
-
Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain
NCT05561023 ·Status: UNKNOWN ·Phase: PHASE1
-
Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face
NCT04485442 ·Status: ACTIVE_NOT_RECRUITING
-
A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the Treatment of Advanced Melanoma
NCT03696069 ·Status: COMPLETED
-
Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain
NCT00306020 ·Status: WITHDRAWN ·Phase: NA
-
Head and Neck Melanoma; Access to Staging and Surgical Treatment
NCT05900102 ·Status: COMPLETED
-
Utility of the Skin Cancer Quality of Life Impact Tool
NCT02580916 ·Status: COMPLETED ·Phase: NA
-
Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma
NCT01455103 ·Status: WITHDRAWN ·Phase: PHASE1
-
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
NCT03199846 ·Status: COMPLETED
-
Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma
NCT00707161 ·Status: TERMINATED ·Phase: PHASE2
-
Melanoma Risk Assessment & Tailored Intervention
NCT01356771 ·Status: COMPLETED ·Phase: NA
-
MoleGazer Development Feasibility Study
NCT05015816 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Cytokine Biomarkers in Melanoma Patients During Immunotherapy
NCT04928365 ·Status: UNKNOWN ·Phase: PHASE2
-
Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
NCT07148245 ·Status: RECRUITING
-
Biomarkers for the Activity of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Melanoma
NCT02673970 ·Status: RECRUITING
-
Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization of Metastatic Melanoma Patients
NCT06369428 ·Status: COMPLETED
-
Skin Care Behaviors Among Melanoma Survivors and Their Families
NCT02457065 ·Status: COMPLETED ·Phase: NA
-
Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.
NCT06994208 ·Status: RECRUITING
-
Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors
NCT03326973 ·Status: COMPLETED
-
Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors
NCT03946007 ·Status: COMPLETED
-
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06400550 ·Status: RECRUITING
-
Malignant Mesothelioma - Can we Improve Quality of Life
NCT03068117 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Functionality of fPAM Imaging in Melanoma
NCT00776945 ·Status: TERMINATED